Guido SilvestriEmory University School of Medicine, Atlanta, GA 30329, USAgsilves@emory.eduMathias LichterfeldThe Brigham and Women’s Hospital and the Ragon Institute of MGH, MIT and Harvard, Boston, MA, USAMLICHTERFELD@mgh.harvard.edu

• Molecular Control of HIV and SIV Latency.- Assays to Measure Latency, Reservoirs and Reactivation.- The Antiviral Immune Response and its Impact on the HIV-1 Reservoir.- Nonhuman Primate Models for Studies of AIDS Virus Persistence During Suppressive Combination Antiretroviral Therapy.- SIV Latency in Macrophages in the CNS.- Mathematical models of HIV latency.- Residual Immune Activation and Latency.- Immune Interventions to Eliminate the HIV Reservoir.- Cell and Gene Therapy for HIV Cure.

Guido SilvestriEmory University School of Medicine, Atlanta, GA 30329, USAgsilves@emory.eduMathias LichterfeldThe Brigham and Women’s Hospital and the Ragon Institute of MGH, MIT and Harvard, Boston, MA, USAMLICHTERFELD@mgh.harvard.edu

• Molecular Control of HIV and SIV Latency.- Assays to Measure Latency, Reservoirs and Reactivation.- The Antiviral Immune Response and its Impact on the HIV-1 Reservoir.- Nonhuman Primate Models for Studies of AIDS Virus Persistence During Suppressive Combination Antiretroviral Therapy.- SIV Latency in Macrophages in the CNS.- Mathematical models of HIV latency.- Residual Immune Activation and Latency.- Immune Interventions to Eliminate the HIV Reservoir.- Cell and Gene Therapy for HIV Cure.